Table 2.
Subgroups overall effect | Number of studies | Heterogeneity test | Egger’s test | Random model | |||||
---|---|---|---|---|---|---|---|---|---|
Prevalence (95% CI) (%) | Z | p | Q | p | I2 | T | p | ||
Int1 | 8 | 40(26.1–55.8) | 1.2 | 0.00 | 74.1 | 0.00 | 90.5 | 1.8 | 0.12 |
MDR | 6 | 70.1(32.6–91.9) | 1 | 0.00 | 119.1 | 0.00 | 95.8 | 0.43 | 0.68 |
Note: Int1: Class 1 integron; MDR: Multi-drug resistant.